Literature DB >> 24046469

Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies.

Olena O Seminog1, Michael J Goldacre.   

Abstract

OBJECTIVE: Some studies suggest that gout is a risk factor for cardiovascular disease. There is more evidence about the association between gout and acute myocardial infarction (MI) than about gout and stroke, and only limited information about risks by age group and sex. We aimed to study MI and stroke following gout, including types of stroke, by age group and comparing men and women.
METHODS: We analysed an all-England national linked dataset of hospital admissions and death records from 1999 to 2011, and a similar dataset in the Oxford Record Linkage Study spanning 1963-98. The occurrence of MI and stroke was estimated in cohorts of patients admitted to hospital with gout, compared with MI and stroke in control cohorts, and the comparisons were expressed as rate ratios (RRs).
RESULTS: The risk of MI and stroke was elevated, and similar, in both datasets. In the all-England dataset, which included 202 033 hospital patients with gout, the RR for MI following gout was 1.82 (95% CI 1.78, 1.85), for all stroke 1.71 (1.68, 1.75), ischaemic stroke 1.68 (1.64, 1.73), haemorrhagic stroke 1.69 (1.61, 1.77) and stroke of unspecified type 2.00 (1.95, 2.06). Associations were stronger in younger than older age groups, and in the younger were stronger in women than men.
CONCLUSION: Gout was associated with increased risk of stroke as well as MI. These findings should be considered by clinicians and may have implications for preventive management of circulatory disease risks in people with gout.

Entities:  

Keywords:  MI; acute stroke; gout; record linkage; risk factors

Mesh:

Year:  2013        PMID: 24046469     DOI: 10.1093/rheumatology/ket293

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  34 in total

Review 1.  Large Artery Atherosclerotic Occlusive Disease.

Authors:  John W Cole
Journal:  Continuum (Minneap Minn)       Date:  2017-02

Review 2.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

3.  Prevalence of calcified carotid artery atheromas on panoramic images of older men with gout: a descriptive retrospective study.

Authors:  Arthur H Friedlander; Lindsay L Graves; Shannon G Grabich; Nona Aghazadehsanai; Tina I Chang
Journal:  Dentomaxillofac Radiol       Date:  2017-03-28       Impact factor: 2.419

Review 4.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

5.  Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.

Authors:  Chien-Fang Huang; Ju-Chi Liu; Hui-Chuan Huang; Shao-Yuan Chuang; Chang-I Chen; Kuan-Chia Lin
Journal:  Rheumatol Int       Date:  2016-12-21       Impact factor: 2.631

Review 6.  Hyperuricemia, gout, and cardiovascular disease: an update.

Authors:  Aryeh M Abeles
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

7.  Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.

Authors:  Seoyoung C Kim; Tuhina Neogi; Eun Ha Kang; Jun Liu; Rishi J Desai; MaryAnn Zhang; Daniel H Solomon
Journal:  J Am Coll Cardiol       Date:  2018-03-06       Impact factor: 24.094

Review 8.  Cardiovascular Safety of Urate Lowering Therapies.

Authors:  Eun Ha Kang; Seoyoung C Kim
Journal:  Curr Rheumatol Rep       Date:  2019-07-24       Impact factor: 4.592

Review 9.  [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].

Authors:  L Sellin; J T Kielstein; K de Groot
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

10.  Risk of incident atrial fibrillation in gout: a cohort study.

Authors:  Seoyoung C Kim; Jun Liu; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2015-08-31       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.